DENTSPLY SIRONA Inc.

NasdaqGS:XRAY Stock Report

Market Cap: US$2.6b

DENTSPLY SIRONA Past Earnings Performance

Past criteria checks 0/6

DENTSPLY SIRONA's earnings have been declining at an average annual rate of -44%, while the Medical Equipment industry saw earnings growing at 14.1% annually. Revenues have been growing at an average rate of 1% per year.

Key information

-44.04%

Earnings growth rate

-45.21%

EPS growth rate

Medical Equipment Industry Growth8.90%
Revenue growth rate0.99%
Return on equity-48.34%
Net Margin-25.85%
Last Earnings Update30 Jun 2025

Recent past performance updates

Recent updates

Dentsply Sirona: Turnaround Potential And Digital Workflows

Aug 19

DENTSPLY SIRONA (NASDAQ:XRAY) Is Due To Pay A Dividend Of $0.16

Aug 11
DENTSPLY SIRONA (NASDAQ:XRAY) Is Due To Pay A Dividend Of $0.16

DENTSPLY SIRONA (NASDAQ:XRAY) Has Some Way To Go To Become A Multi-Bagger

Jul 22
DENTSPLY SIRONA (NASDAQ:XRAY) Has Some Way To Go To Become A Multi-Bagger

DENTSPLY SIRONA (NASDAQ:XRAY) Will Pay A Dividend Of $0.16

May 30
DENTSPLY SIRONA (NASDAQ:XRAY) Will Pay A Dividend Of $0.16

DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) CEO Might Not Expect Shareholders To Be So Generous This Year

May 15
DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) CEO Might Not Expect Shareholders To Be So Generous This Year

Earnings Beat: DENTSPLY SIRONA Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

May 11
Earnings Beat: DENTSPLY SIRONA Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) Share Price Boosted 26% But Its Business Prospects Need A Lift Too

May 09
DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) Share Price Boosted 26% But Its Business Prospects Need A Lift Too
User avatar

Revamped E-commerce And Imaging Products Will Secure Success

Strategic divestment of Wellspect HealthCare aims to unlock value and improve net margins, leveraging its growth and profitability.

Here's Why DENTSPLY SIRONA (NASDAQ:XRAY) Has A Meaningful Debt Burden

Apr 29
Here's Why DENTSPLY SIRONA (NASDAQ:XRAY) Has A Meaningful Debt Burden

DENTSPLY SIRONA (NASDAQ:XRAY) Has More To Do To Multiply In Value Going Forward

Apr 08
DENTSPLY SIRONA (NASDAQ:XRAY) Has More To Do To Multiply In Value Going Forward

DENTSPLY SIRONA (NASDAQ:XRAY) Has Affirmed Its Dividend Of $0.16

Mar 18
DENTSPLY SIRONA (NASDAQ:XRAY) Has Affirmed Its Dividend Of $0.16

Weak Results And Poor Growth Prospects Have Dentsply Sirona Deep In The Street's Doghouse

Mar 05

Benign Growth For DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Underpins Its Share Price

Feb 13
Benign Growth For DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Underpins Its Share Price

DENTSPLY SIRONA (NASDAQ:XRAY) Has A Somewhat Strained Balance Sheet

Jan 08
DENTSPLY SIRONA (NASDAQ:XRAY) Has A Somewhat Strained Balance Sheet

Is Now An Opportune Moment To Examine DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?

Dec 21
Is Now An Opportune Moment To Examine DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Could Be 40% Below Their Intrinsic Value Estimate

Dec 03
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Could Be 40% Below Their Intrinsic Value Estimate

Dentsply Sirona: No Change To Operating Mechanics Despite Extensive Review

Nov 27

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough

Nov 11
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough

DENTSPLY SIRONA (NASDAQ:XRAY) Hasn't Managed To Accelerate Its Returns

Oct 13
DENTSPLY SIRONA (NASDAQ:XRAY) Hasn't Managed To Accelerate Its Returns

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Looks Inexpensive But Perhaps Not Attractive Enough

Sep 25
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Looks Inexpensive But Perhaps Not Attractive Enough

Is It Time To Consider Buying DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?

Sep 05
Is It Time To Consider Buying DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?

Is There An Opportunity With DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) 21% Undervaluation?

Aug 18
Is There An Opportunity With DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) 21% Undervaluation?

Returns On Capital At DENTSPLY SIRONA (NASDAQ:XRAY) Have Hit The Brakes

Jul 11
Returns On Capital At DENTSPLY SIRONA (NASDAQ:XRAY) Have Hit The Brakes

A Tough Macro Environment Makes Dentsply Sirona's Turnaround Even Harder

Jul 02

Insufficient Growth At DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Hampers Share Price

Jun 11
Insufficient Growth At DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Hampers Share Price

We Think DENTSPLY SIRONA (NASDAQ:XRAY) Can Stay On Top Of Its Debt

May 24
We Think DENTSPLY SIRONA (NASDAQ:XRAY) Can Stay On Top Of Its Debt

Dentsply Sirona: I'm Buying The Pullback In This Medtech Leader

Apr 24

Are Investors Undervaluing DENTSPLY SIRONA Inc. (NASDAQ:XRAY) By 47%?

Apr 22
Are Investors Undervaluing DENTSPLY SIRONA Inc. (NASDAQ:XRAY) By 47%?

There's No Escaping DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) Muted Revenues

Mar 10
There's No Escaping DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) Muted Revenues

Here's Why DENTSPLY SIRONA (NASDAQ:XRAY) Has A Meaningful Debt Burden

Feb 16
Here's Why DENTSPLY SIRONA (NASDAQ:XRAY) Has A Meaningful Debt Burden

DENTSPLY SIRONA (NASDAQ:XRAY) Has More To Do To Multiply In Value Going Forward

Jan 29
DENTSPLY SIRONA (NASDAQ:XRAY) Has More To Do To Multiply In Value Going Forward

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Could Be 28% Below Their Intrinsic Value Estimate

Jan 11
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Could Be 28% Below Their Intrinsic Value Estimate

Is It Too Late To Consider Buying DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?

Nov 25
Is It Too Late To Consider Buying DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?

These 4 Measures Indicate That DENTSPLY SIRONA (NASDAQ:XRAY) Is Using Debt Extensively

Nov 06
These 4 Measures Indicate That DENTSPLY SIRONA (NASDAQ:XRAY) Is Using Debt Extensively

Revenue & Expenses Breakdown

How DENTSPLY SIRONA makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

NasdaqGS:XRAY Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 253,671-9491,469155
31 Mar 253,719-9081,526159
31 Dec 243,793-9101,581165
30 Sep 243,900-4131,612166
30 Jun 243,896-1851,596172
31 Mar 243,940-951,611180
31 Dec 233,965-1321,617184
30 Sep 233,936-2141,612184
30 Jun 233,936-1,0251,641179
31 Mar 233,931-1,0381,638175
31 Dec 223,922-9501,596174
30 Sep 224,042-8161,564180
30 Jun 224,1353451,552178
31 Mar 224,1743681,536176
31 Dec 214,2314111,547171
30 Sep 214,2074011,535166
30 Jun 214,0623701,458154
31 Mar 213,4911791,323129
31 Dec 203,339-731,309123
30 Sep 203,371-801,275210
30 Jun 203,438-481,340183
31 Mar 203,957841,510165
31 Dec 194,0222561,578143
30 Sep 193,9771621,520161
30 Jun 193,9441051,560161
31 Mar 193,976-1,0531,562161
31 Dec 183,986-1,0111,551161
30 Sep 184,018-1,6631,560152
30 Jun 184,098-1,6011,578152
31 Mar 184,049-1,5291,563152
31 Dec 173,993-1,5501,532152
30 Sep 173,899-7931,501129
30 Jun 173,844-7911,443129
31 Mar 173,8733651,427129
31 Dec 163,7454301,374129
30 Sep 163,4203821,30775
30 Jun 163,1153741,19275
31 Mar 162,7913121,06575
31 Dec 152,67425199375
30 Sep 152,7222771,01181
30 Jun 152,7822681,01781
31 Mar 152,8493141,03881
31 Dec 142,9233231,06281

Quality Earnings: XRAY is currently unprofitable.

Growing Profit Margin: XRAY is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: XRAY is unprofitable, and losses have increased over the past 5 years at a rate of 44% per year.

Accelerating Growth: Unable to compare XRAY's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: XRAY is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (12.6%).

Return on Equity

High ROE: XRAY has a negative Return on Equity (-48.34%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/10/05 14:24
End of Day Share Price 2025/10/03 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

DENTSPLY SIRONA Inc. is covered by 36 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jeffrey JohnsonBaird
Lawrence MarshBarclays
Michael PetuskyBarrington Research Associates, Inc.